| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/013 |
Exforge HCT, Film coated tablet, 10 mg/160 mg/12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
14.73 |
2.95 |
17.68 |
6% |
0.88 |
15.61 |
3.12 |
18.73 |
18% |
2.65 |
18.26 |
3.65 |
21.91 |
Промяна на обстоятелствата НСР-16309/27.07.2018. |
НСР-6901/06.08.2015. |
21.08.2015 |
02.09.2018 |
Активен |
3214 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/013 |
Exforge HCT, Film coated tablet, 10 mg/ 160 mg/ 12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
14.73 |
2.95 |
17.68 |
6% |
0.88 |
15.61 |
3.12 |
18.73 |
18% |
2.65 |
18.26 |
3.65 |
21.91 |
|
НСР-6901/06.08.2015. |
21.08.2015 |
21.08.2015 |
Неактивен |
3214 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/001 |
Exforge HCT, Film coated tablet, 5 mg/ 160 mg/ 12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Germany |
16.7 |
3.34 |
20.04 |
6% |
1 |
17.7 |
3.54 |
21.24 |
18% |
3.01 |
20.71 |
4.14 |
24.85 |
|
НСР-5540/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3529 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/013 |
Exforge HCT, Film coated tablet, 10 mg/ 160 mg/ 12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
14.75 |
2.95 |
17.7 |
6% |
0.89 |
15.64 |
3.13 |
18.77 |
18% |
2.66 |
18.3 |
3.66 |
21.96 |
|
НСР-4732/02.10.2014 |
16.10.2014 |
16.10.2014 |
Неактивен |
3214 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/001 |
Exforge HCT, Film coated tablet, 5 mg/ 160 mg/ 12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbHq Germany |
21.55 |
4.31 |
25.86 |
6% |
1.29 |
22.84 |
4.57 |
27.41 |
18% |
3.88 |
26.72 |
5.34 |
32.06 |
|
НСР-1790/21.11.2013 |
09.12.2013 |
09.12.2013 |
Неактивен |
3529 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/001 |
Exforge HCT, Film coated tablet, 5 mg/ 160 mg/ 12,5 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbHq Germany |
23.55 |
4.71 |
28.26 |
6% |
1.41 |
24.96 |
4.99 |
29.95 |
18% |
4.24 |
29.2 |
5.84 |
35.04 |
|
КЦ-2023/25.02.2011 |
14.03.2011 |
14.03.2011 |
Неактивен |
3529 |
| Amlodipine, Valsartan, Hydrochlorothiazide |
EU/1/09/569/037 |
Exforge HCT, Film coated tablet, 10 mg/ 160 mg/ 25 mg, mg, Pack: 14 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbHq Germany |
25.46 |
5.09 |
30.55 |
6% |
1.53 |
26.99 |
5.4 |
32.39 |
18% |
4.58 |
31.57 |
6.31 |
37.88 |
|
КЦ-1803/11.10.2010 |
16.11.2010 |
16.11.2010 |
Неактивен |
967 |
| Deferasirox |
EU/1/06/356/014 |
Exjade, Film coated tablet, 180, mg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
572.88 |
114.58 |
687.46 |
4% |
10 |
582.88 |
116.58 |
699.46 |
16% |
25 |
607.88 |
121.58 |
729.46 |
Промяна на обстоятелствата НСР-16384/02.08.2018 |
НСР-15644/10.05.2018; НСР-17567/20.12.2018 |
04.01.2019 |
02.02.2019 |
Активен |
16126 |
| Deferasirox |
EU/1/06/356/014 |
Exjade, Film coated tablet, 180, mg, Pack: 30 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
586.61 |
117.32 |
703.93 |
4% |
10 |
596.61 |
119.32 |
715.93 |
16% |
25 |
621.61 |
124.32 |
745.93 |
Промяна на обстоятелствата НСР-16384/02.08.2018 |
НСР-15644/10.05.2018 |
25.05.2018 |
02.09.2018 |
Неактивен |
16126 |
| Deferasirox |
EU/1/06/356/014 |
Exjade, Film coated tablet, 180, mg, Pack: 30 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
586.61 |
117.32 |
703.93 |
4% |
10 |
596.61 |
119.32 |
715.93 |
16% |
25 |
621.61 |
124.32 |
745.93 |
|
НСР-15644/10.05.2018 |
25.05.2018 |
02.06.2018 |
Неактивен |
16126 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
532.3 |
106.46 |
638.76 |
4% |
10 |
542.3 |
108.46 |
650.76 |
16% |
25 |
567.3 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015; НСР-16382/02.08.2018 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение); НСР-17799/24.01.2019 |
02.03.2019 |
02.03.2019 |
Заличен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Ирландия |
Novartis Pharma GmbH, Германия |
532.3 |
106.46 |
638.76 |
4% |
10 |
542.3 |
108.46 |
650.76 |
16% |
25 |
567.3 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015; НСР-16382/02.08.2018 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение) |
22.03.2018 |
02.09.2018 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
532.3 |
106.46 |
638.76 |
4% |
10 |
542.3 |
108.46 |
650.76 |
16% |
25 |
567.3 |
113.46 |
680.76 |
промяна в обстоятелствата НСР-6995/24.08.2015 |
НСР-5519/29.01.2015; НСР-15279/22.03.2018 (предварително изпълнение) |
22.03.2018 |
02.04.2018 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
569.05 |
113.81 |
682.86 |
4% |
10 |
579.05 |
115.81 |
694.86 |
16% |
25 |
604.05 |
120.81 |
724.86 |
промяна в обстоятелствата НСР-6995/24.08.2015 |
НСР-5519/29.01.2015 |
12.02.2015 |
12.02.2015 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
577.48 |
115.5 |
692.98 |
4% |
10 |
587.48 |
117.5 |
704.98 |
16% |
25 |
612.48 |
122.5 |
734.98 |
|
НСР-3731/06.06.2014 |
23.06.2014 |
23.06.2014 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Pharma GmbH, Германия |
Novartis Pharma GmbH, Германия |
584.32 |
116.86 |
701.18 |
4% |
10 |
594.32 |
118.86 |
713.18 |
16% |
25 |
619.32 |
123.86 |
743.18 |
|
НСР-1432/10.10.2013 |
25.10.2013 |
25.10.2013 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
619.06 |
123.81 |
742.87 |
4% |
10 |
629.06 |
125.81 |
754.87 |
16% |
25 |
654.06 |
130.81 |
784.87 |
|
КЦРР-922/04.07.2012 |
19.07.2012 |
19.07.2012 |
Неактивен |
3539 |
| Deferasirox |
EU/1/06/356/003 |
Exjade, Dispersible tablet, 250, mg, Pack: 28 |
Novartis Europharm Limited, Обединено Кралство |
Novartis Pharma GmbH, Германия |
683.58 |
136.72 |
820.3 |
6% |
15 |
698.58 |
139.72 |
838.3 |
18% |
30 |
728.58 |
145.72 |
874.3 |
|
КЦ-531/19.02.2009 |
13.03.2009 |
13.03.2009 |
Неактивен |
3539 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
33.95 |
6.79 |
40.74 |
4% |
1.36 |
35.31 |
7.06 |
42.37 |
16% |
5.43 |
40.74 |
8.15 |
48.89 |
|
НСР-8564/24.03.2016.; НСР-12178/27.03.2017 |
08.04.2016 |
02.05.2017 |
Заличен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
33.95 |
6.79 |
40.74 |
4% |
1.36 |
35.31 |
7.06 |
42.37 |
16% |
5.43 |
40.74 |
8.15 |
48.89 |
|
НСР-8564/24.03.2016. |
08.04.2016 |
08.04.2016 |
Неактивен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
16.98 |
3.4 |
20.38 |
6% |
1.02 |
18 |
3.6 |
21.6 |
18% |
3.06 |
21.06 |
4.21 |
25.27 |
|
НСР-8563/24.03.2016. |
08.04.2016 |
08.04.2016 |
Активен |
386 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 200 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
61.39 |
12.28 |
73.67 |
4% |
2.46 |
63.85 |
12.77 |
76.62 |
16% |
9.82 |
73.67 |
14.73 |
88.4 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
387 |
| Fluconazole |
16007/23.02.2007 г. |
EXOMAX, Solution for infusion, 2 mg/ml - 100 ml, mg, Pack: 1 |
Claris Lifesciences (UK) Ltd, Обединено Кралство |
Екофарм ЕООД |
32.41 |
6.48 |
38.89 |
4% |
1.3 |
33.71 |
6.74 |
40.45 |
16% |
5.19 |
38.9 |
7.78 |
46.68 |
промяна в обстоятелствата КЦPP-2270/11.02.2013 |
КЦ-390/07.01.2009 |
04.02.2009 |
04.02.2009 |
Неактивен |
386 |
| Aripiprazole |
20150245 |
Explemed, Tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLCH-1165 Budapest, Bökényföldiút 118-120.Унгария |
60.53 |
12.11 |
72.64 |
4% |
2.42 |
62.95 |
12.59 |
75.54 |
16% |
9.68 |
72.63 |
14.53 |
87.16 |
|
НСР-7029/25.08.2015; НСР-11086/01.12.2016 г. |
17.12.2016 |
02.01.2017 |
Активен |
4067 |
| Aripiprazole |
20150245 |
Explemed, Tablet, 15, mg, Pack: 28 |
EGIS Pharmaceuticals PLC, Унгария |
EGIS Pharmaceuticals PLCH-1165 Budapest, Bökényföldiút 118-120.Унгария |
84.75 |
16.95 |
101.7 |
4% |
3.39 |
88.14 |
17.63 |
105.77 |
16% |
13.56 |
101.7 |
20.34 |
122.04 |
|
НСР-7029/25.08.2015 |
09.09.2015 |
09.09.2015 |
Неактивен |
4067 |